Zealand Pharma As Stock Overlap Studies Midpoint Price over period

ZLDPF Stock  USD 104.20  1.45  1.41%   
Zealand Pharma overlap studies tool provides the execution environment for running the Midpoint Price over period study and other technical functions against Zealand Pharma. Zealand Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Midpoint Price over period study function is designed to identify and follow existing trends. Zealand Pharma overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Mid-point Price over period is an average of Zealand Pharma AS highest and lowest prices attained during the given period.

Zealand Pharma Technical Analysis Modules

Most technical analysis of Zealand Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zealand from various momentum indicators to cycle indicators. When you analyze Zealand charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Zealand Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zealand Pharma AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zealand Pharma AS based on widely used predictive technical indicators. In general, we focus on analyzing Zealand Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zealand Pharma's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Zealand Pharma's intrinsic value. In addition to deriving basic predictive indicators for Zealand Pharma, we also check how macroeconomic factors affect Zealand Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Hype
Prediction
LowEstimatedHigh
101.12104.20107.28
Details
Intrinsic
Valuation
LowRealHigh
89.1992.27114.62
Details
Naive
Forecast
LowNextHigh
91.8594.9498.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
87.14108.16129.18
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in Zealand Pink Sheet

Zealand Pharma financial ratios help investors to determine whether Zealand Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zealand with respect to the benefits of owning Zealand Pharma security.